Health Populi

JUNE 24, 2021

The last point on “new technologies” begs the question, “who” will fund innovation in health care as we emerge from the pandemic with national economics growing back at different paces, and employment in a very different context than pre-pandemic.

BioTech 270

BioTech Pharmaceuticals Public Health Telehealth 270

Health Populi

MARCH 11, 2021

The coolest thing in health policy in the 21st century!! ” Amitabh Chandra gave the opening context-setting talk about the effects of health care cost-sharing on patients-as-consumers. Kavita Patel to assert in the first panel of the day that, “2713 is my favorite number.”

Health Policy 254

Health Policy Medicare Pharmaceuticals Life Science 254

Health Populi

MAY 4, 2023

First, we look at the macro picture on health services utilization comparing the end of 2022 with pre-COVID-19 levels. we see an over-indexing of office, institutional and telehealth visits (at 108) and a 104 gauge on new prescriptions.

Public Health 156

Public Health Mental health Life Science Telehealth 156

Health Populi

JUNE 18, 2020

In today’s pharma/biotech market, the “specialty” label is given to many therapies: for products addressing rare diseases, risk-management, and above all, high cost drugs. The phrase “specialty drugs” originated in the 1970s in the advent of injectable and infusion therapies. Other countries outside of the U.S.

BioTech 199

BioTech Medicare Life Science Telehealth 199

Health Populi

AUGUST 16, 2021

There is one health care public policy issue that unites U.S. Integrating with the telehealth service Care on the Optum Store. This last aspect is taking a strategic page out of the playbooks of Hims, Nurx, Ro, Truepill and other DTC-facing prescription drug + telehealth services that have proliferated in the U.S.

Pharmaceuticals 334

Pharmaceuticals Telehealth BioTech Mental health 334